Wildfire Smoke Now Kills 41,000 Americans a Year, Study Finds

Every summer, hazy skies and the smell of burning wood remind Americans that wildfires affect far more than just the communities where they ignite.

Their smoke drifts for hundreds, even thousands of miles, darkening the air in cities across the nation. But the health impact goes far beyond watery eyes and coughs.

A new study shows wi...

West Coast States Issue Their Own COVID, Flu, RSV Vaccine Rules

Four Western states are taking a different approach from the U.S. Centers for Disease Control and Prevention (CDC) on vaccines for COVID-19, flu and RSV.

California, Hawaii, Oregon and Washington — now working together as the West Coast Health Alliance — issued joint guidance Wednesday encouraging broader vaccine use than what&...

Mouth Microbes Might Contribute To Pancreatic Cancer

A person’s risk of pancreatic cancer might be tied to the microbes living in their mouths, a new study says.

People have a more than tripled risk of pancreatic cancer if their mouths contain 27 types of bacteria and fungi, including some directly linked to gum disease, researchers reported Sept. 18 in JAMA Oncology.

&l...

Sepsis Risk Doubled With Type 2 Diabetes

Type 2 diabetes appears to double a person’s risk for life-threatening sepsis, a new study says.

Men and people under 60 with diabetes are particularly at risk for sepsis, a condition in which the immune system overreacts to infection, researchers reported this week at the annual meeting of the European Association for the Study of D...

Weight-Loss Surgery Outperforms GLP-1 Drugs, Study Argues

Cutting-edge drugs like Ozempic and Zepbound are all the rage for dropping excess pounds, but weight-loss surgery might have a better impact on people’s health, a new study says.

People who had weight-loss surgery lost more weight, lived longer and faced fewer serious health problems compared to those prescribed GLP-1 drugs, research...

GLP-1 Pill Effective For Weight Loss, Clinical Trials Show

An effective weight-loss pill to rival injectable drugs like Ozempic and Zepbound might be on the horizon, clinical trial results show.

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, according to final clinical trial results published Sept. 16 in The New England J...